UK markets open in 3 hours 41 minutes

Adverum Biotechnologies, Inc. (ADVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.39-0.80 (-7.85%)
At close: 04:00PM EDT
9.57 +0.18 (+1.92%)
After hours: 05:17PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
3,600
0
7,500
0
Operating expenses
Research development
99,602
77,676
99,277
89,181
73,309
Selling general and administrative
58,012
49,915
57,858
64,441
44,641
Total operating expenses
157,614
127,591
157,135
153,622
117,950
Operating income or loss
-157,614
-123,991
-157,135
-146,122
-117,950
Total other income/expenses net
1,460
5,748
2,673
582
1,557
Income before tax
-156,154
-118,243
-154,462
-145,540
-116,393
Income tax expense
55
-1,078
74
0
1,114
Income from continuing operations
-156,209
-117,165
-154,536
-145,540
-117,507
Net income
-156,209
-117,165
-154,536
-145,540
-117,507
Net income available to common shareholders
-156,209
-117,165
-154,536
-145,540
-117,507
Basic EPS
-1.26
-
-1.56
-1.48
-1.38
Diluted EPS
-1.26
-
-1.56
-1.48
-1.38
Basic average shares
100,501
-
99,251
98,039
85,146
Diluted average shares
100,501
-
99,251
98,039
85,146